Y-Mabs Therapeutics Inc (YMAB) last year’s performance of -70.30% is a clear signal for an entertaining trading season.
On Tuesday, Y-Mabs Therapeutics Inc (NASDAQ: YMAB) opened lower -4.43% from the last session, before settling in for the closing price of $5.19. Price fluctuations